Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy
Open Access
- 21 June 2016
- journal article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 129 (11), 1198-1204
- https://doi.org/10.1016/j.amjmed.2016.05.041
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Antithrombotic Therapy for VTE DiseaseSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2016
- Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needsThe Lancet, 2015
- Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatmentsThe Lancet, 2015
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive SummaryCirculation, 2014
- Meta‐analysis of the efficacy and safety of new oral anticoagulants in patients with cancer‐associated acute venous thromboembolismJournal of Thrombosis and Haemostasis, 2014
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsThe Lancet, 2014
- European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillationEP Europace, 2013
- Apixaban versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2011
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationThe New England Journal of Medicine, 2011
- Dabigatran versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2009